Marc Rubin

Marc Rubin is recorded as Board Member at Curis Inc (CRIS). The newest filing on record that lists Marc Rubin as Board Member at Curis Inc (CRIS) is dated April 21, 2026. Earlier roles on record: Board Member at Galectin Therapeutics Inc (GALT) until January 10, 2026. Galectin Therapeutics Inc reported in an 8-K filed January 12, 2026 that Marc Rubin resigned as Board of Directors, effective January 10, 2026. Curis Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Curis Inc includes James Dentzer (CEO and Board Member), James E. Dentzer (CEO and Board Member), Martyn D. Greenacre (Chairman and Board Member) and 7 others.